Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

GT Biopharma Inc (GTBP)

GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

GT Biopharma Inc 315 Montgomery Street 10th Floor San Francisco CA 94104 USA

www.gtbiopharma.com Employees: 1 P: 415-919-4040

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

GT Biopharma Inc. is an immuno-oncology company. It discovers, develops and commercializes drugs of therapeutic molecules for the treatment of cancer, myeloma, osteolytic lesions and other unmet medical needs. GT Biopharma Inc., formerly known as OXIS International Inc., is based in Tampa, Florida.

Key Statistics

Overview:

Market Capitalization, $K 14,783
Enterprise Value, $K 7,873
Shares Outstanding, K 31,554
Float, K 30,481
% Float 96.60%
Short Interest, K 2,089
Short Float 19.64%
Days to Cover 2.26
Short Volume Ratio 0.52
% of Insider Shareholders 3.40%
% of Institutional Shareholders 8.15%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -28,350 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -23,030 K
EBIT, $ -12,410 K
EBITDA, $ -12,410 K

Growth:

1-Year Return -79.61%
3-Year Return -97.16%
5-Year Return -99.78%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.24%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 03/02/26
Next Earnings Date 05/21/26
Earnings Per Share ttm -2.16
EPS Growth vs. Prev Qtr 97.59%
EPS Growth vs. Prev Year 98.80%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-30 on 02/05/24

GTBP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -116.67%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow 30.75
Price/Book 2.03
Book Value/Share 0.23
Interest Coverage -217.08
60-Month Beta 1.29
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.